Improvement of dose distribution in phantom by using epithermal neutron source based on the Be(p,n) reaction using a 30 MeV proton cyclotron accelerator
- PMID: 19376720
- DOI: 10.1016/j.apradiso.2009.03.096
Improvement of dose distribution in phantom by using epithermal neutron source based on the Be(p,n) reaction using a 30 MeV proton cyclotron accelerator
Abstract
In order to generate epithermal neutrons for boron neutron capture therapy (BNCT), we proposed the method of filtering and moderating fast neutrons, which are emitted from the reaction between a beryllium target and 30 MeV protons accelerated by a cyclotron, using an optimum moderator system composed of iron, lead, aluminum, calcium fluoride, and enriched (6)LiF ceramic filter. At present, the epithermal-neutron source is under construction since June 2008 at Kyoto University Research Reactor Institute. This system consists of a cyclotron to supply a proton beam of about 1 mA at 30 MeV, a beam transport system, a beam scanner system for heat reduction on the beryllium target, a target cooling system, a beam shaping assembly, and an irradiation bed for patients. In this article, an overview of the cyclotron-based neutron source (CBNS) and the properties of the treatment neutron beam optimized by using the MCNPX Monte Carlo code are presented. The distribution of the RBE (relative biological effectiveness) dose in a phantom shows that, assuming a (10)B concentration of 13 ppm for normal tissue, this beam could be employed to treat a patient with an irradiation time less than 30 min and a dose less than 12.5 Gy-eq to normal tissue. The CBNS might be an alternative to the reactor-based neutron sources for BNCT treatments.
Similar articles
-
Benchmark experiments for cyclotron-based neutron source for BNCT.Appl Radiat Isot. 2004 Nov;61(5):997-1001. doi: 10.1016/j.apradiso.2004.05.025. Appl Radiat Isot. 2004. PMID: 15308182
-
Optimization of an accelerator-based epithermal neutron source for neutron capture therapy.Appl Radiat Isot. 2004 Nov;61(5):1009-13. doi: 10.1016/j.apradiso.2004.05.028. Appl Radiat Isot. 2004. PMID: 15308184
-
A neutron producing target for BINP accelerator-based neutron source.Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S282-4. doi: 10.1016/j.apradiso.2009.03.076. Epub 2009 Mar 27. Appl Radiat Isot. 2009. PMID: 19376729
-
Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors.J Neurooncol. 2003 Mar-Apr;62(1-2):19-31. doi: 10.1007/BF02699931. J Neurooncol. 2003. PMID: 12749700 Review.
-
From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.Cancer Biother Radiopharm. 2023 Apr;38(3):184-191. doi: 10.1089/cbr.2022.0059. Epub 2022 Oct 21. Cancer Biother Radiopharm. 2023. PMID: 36269660 Review.
Cited by
-
Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance.Cancers (Basel). 2024 Feb 21;16(5):869. doi: 10.3390/cancers16050869. Cancers (Basel). 2024. PMID: 38473231 Free PMC article.
-
Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study.J Radiat Res. 2022 May 18;63(3):393-401. doi: 10.1093/jrr/rrac012. J Radiat Res. 2022. PMID: 35388879 Free PMC article.
-
Determining a methodology of dosimetric quality assurance for commercially available accelerator-based boron neutron capture therapy system.J Radiat Res. 2022 Jul 19;63(4):620-635. doi: 10.1093/jrr/rrac030. J Radiat Res. 2022. PMID: 35726375 Free PMC article.
-
Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era.Int J Clin Oncol. 2020 Jan;25(1):43-50. doi: 10.1007/s10147-019-01480-4. Epub 2019 Jun 5. Int J Clin Oncol. 2020. PMID: 31168726 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources